Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.22
-0.04 (-3.17%)
At close: Aug 18, 2025, 3:59 PM
1.23
0.80%
After-hours: Aug 18, 2025, 07:25 PM EDT

Marker Therapeutics Revenue

Marker Therapeutics reported an annual revenue of $6.59M, reflecting a 99.06% growth. For the quarter ending March 31, 2025, Marker Therapeutics generated $349.1K in revenue.
Revenue (ttm)
6.59M
Revenue Growth
99.06%
Price / Sales Ratio
4.24
Revenue / Employee
1.32M
Employees
5
Market Cap
13.8M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 6.59M +99.06%
Dec 31, 2023 3.31M -63.23%
Dec 31, 2022 9.01M +625.04%
Dec 31, 2021 1.24M +166.08%
Dec 31, 2020 466.79K +118.95%
Dec 31, 2019 213.19K +3.50%
Dec 31, 2018 205.99K +12.53%
Dec 31, 2017 183.06K +Infinity%
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Dec 31, 2011 0 n/a
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 n/a
Dec 31, 2007 0 n/a
Dec 31, 2006 0 n/a
Dec 31, 2005 0 n/a
Dec 31, 2004 0 n/a
Dec 31, 2003 0 n/a
Dec 31, 2002 0 n/a
Dec 31, 2001 0 -100.00%
Dec 31, 2000 31.81K -73.65%
Dec 31, 1999 120.72K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.